Brewing up plant-inspired medicines

A yeast-based biomanufacturing platform pioneered by US-based synthetic biology company Antheia aims to replace growing, harvesting and extracting complex molecules from plants to make natural product-derived drugs.

This could shorten the production timeline for crucial medicines from as much as five years down to a matter of weeks. The approach reconstructs multi-step biochemical pathways for producing complex molecules, offering an alternative to conventional synthetic chemistry.